Meet Axvia AI
_mp4.jpg)
Axvia AI is being developed as a clinical decision-support platform that combines patient characteristics, treatment factors, laboratory biomarkers, and clinical monitoring data to assess elevated ICANS risk. The goal is to provide interpretable risk insights that complement clinical assessment and support earlier, more informed monitoring.
01.
Relevant patient information is collected throughout care.
Data Acquisition
.png)
02.
AI/ML models evaluate patterns associated with ICANS risk.
Risk Assessment
%20(1).png)
03.
Risk information is presented with context to help clinicians understand changes in risk.
Clinical Insights
%20(2).png)
04.
Risk information supports closer monitoring and clinical assessment.
Proactive Monitoring
%20(3).png)
Why Earlier Risk Identification Matters
As CAR-T adoption grows, the need for earlier ICANS risk detection becomes increasingly critical.
.png)
Up to 70%
Develop ICANS
700+
Patients Treated in Canada
34,000+
Global CAR-T Recipients
1 Mission
Earlier ICANS Detection
Get in Touch
We're here to help and answer any question you might have.